Noso N, Proost P, Van Damme J, Schröder J M
Department of Dermatology, University of Kiel, Germany.
Biochem Biophys Res Commun. 1994 May 16;200(3):1470-6. doi: 10.1006/bbrc.1994.1616.
When synthetic monocyte chemotactic proteins (MCPs) were tested in a Boyden chamber assay system for eosinophil-chemotactic properties using human eosinophils, MCP-3 was found to be a potent and efficient (percentage input migrating cells) attractant with an ED50 near 2-3 nM. MCP-2 was less potent, exhibiting half maximal chemotaxis at 40 nM. Cross desensitization experiments of eosinophil-chemotaxis revealed that both MCP-3 and MCP-2 desensitized autologous responses. In addition, pretreatment of human eosinophils with natural RANTES desensitized chemotaxis towards MCP-3 as well as MCP-2, whereas pretreatment of eosinophils with MCP-3 desensitized, apart from responses to MCP-3, also responses against RANTES and MCP-2. These findings indicate that possibly both MCP-3 and MCP-2 elicit chemotactic responses via the RANTES-receptor on eosinophils.
当使用人嗜酸性粒细胞在博伊登小室分析系统中测试合成单核细胞趋化蛋白(MCPs)的嗜酸性粒细胞趋化特性时,发现MCP-3是一种强效且高效(迁移细胞输入百分比)的趋化剂,ED50接近2-3 nM。MCP-2的效力较弱,在40 nM时表现出半数最大趋化作用。嗜酸性粒细胞趋化的交叉脱敏实验表明,MCP-3和MCP-2均使自身反应脱敏。此外,用天然调节激活正常T细胞表达和分泌因子(RANTES)预处理人嗜酸性粒细胞可使对MCP-3以及MCP-2的趋化作用脱敏,而用MCP-3预处理嗜酸性粒细胞,除了对MCP-3的反应脱敏外,还使对RANTES和MCP-2的反应脱敏。这些发现表明,MCP-3和MCP-2可能都通过嗜酸性粒细胞上的RANTES受体引发趋化反应。